MedTrace Logo

To Assess the Effect of Collagen on Gastrointestinal Discomfort in Healthy Adults With Gastrointestinal Symptoms.

NCT06937801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2026-05-01

No results posted yet for this study

Summary

This study will enroll healthy adults with perceived gastrointestinal symptoms to evaluate the effect of collagen peptides compared to placebo.

Conditions

  • Gastrointestinal Disorders

Interventions

DIETARY_SUPPLEMENT

Collagen Peptide

10g Collagen Hydrolysate per sachet

OTHER

Placebo

Placebo - active ingredients: N/A

Sponsors & Collaborators

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    collaborator NETWORK

  • Rousselot BVBA

    lead INDUSTRY

Principal Investigators

  • Nicoletta Virgilio · Rousselot BV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-08
Primary Completion
2025-11-21
Completion
2025-11-21

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06937801 on ClinicalTrials.gov